The global craniomaxillofacial implants market is estimated to reach USD 4,038.2 million by the end of 2028. The increase in the number of road accidents across the world is the major factor driving the growth of the market. Furthermore, rising cases of trauma and injuries are another factor that promotes the growth of the market. In addition, increasing demand for minimally invasive surgeries also assists in booming the growth of the craniomaxillofacial implants market. Moreover, the penetration of improved and technologically advanced therapies in the global market is the major contributing factor that promotes the growth of the market. However, the high cost of the procedure followed by lack of skilled professionals is the major restraining cause that affects the growth of the market. It is expected that the untapped market of developing economies will bring huge opportunities during the forecasted year.
Craniomaxillofacial implants defined as a product designed to repair the mouth, jaws, face, skull, and all the relating structures. The product is intently used for people who are suffering from craniomaxillofacial trauma due to accidents or other physical injuries. Severe craniomaxillofacial injuries sometimes left the body to compromise the function of smell, taste, or breath. These injuries mostly left with major psychological consequences. The patient of craniomaxillofacial also seems to be rejected by the social environment. Many manufacturers are keen in designing the various implant which assists in maintaining the proper structure of the face. Some of the common products used under procedures are Cranium, Midface, Mandible, and orthognathic types.
The Covid 19 pandemic first entered in 2019 and later it disrupted society at the global level. The doctor is giving the first preference to COVID patients and emergency patients followed by the others. Despite the increasing load, medical professionals are giving top priority to trauma patients. In this Covid 19 era, Doctor's ultimate goal is to cover the maximum number of patients of medical emergencies. Covid 19 do less to no impact on the craniomaxillofacial implant market, due to its medical emergency condition.
The major players operating in the global craniomaxillofacial implants market include but are not limited to Stryker, KLS Martin, Depuy Synthes, Zimmer Biomet, Medtronic, Integra Lifesciences, OsteoMed, Medartis AG, Matrix Surgical USA, and Calavera among others.
Craniomaxillofacial Implants Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2028||USD 4,038.2 Million|
|Growth Rate||CAGR of 7.0% during 2021-2028|
|Segment Covered||Product Type, Application Site, Material Type, Property, Regions|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, Middle East & Africa|
|Key Players Profiled||Stryker, KLS Martin, Depuy Synthes, Zimmer Biomet, Medtronic, Integra Lifesciences, OsteoMed, Medartis AG, Matrix Surgical USA, and Calavera among others. The proliferation of local manufacturers is also significant in this market, thus intensifying the prevalent competition.|
Reasons for the study
- To know the current and the future demand from the end-user industry
- To know the number of procedure carried out globally
- Need for the medical facilities required for craniomaxillofacial implants
- To understand the beneficiary effect of craniomaxillofacial implants
What does the report include?
- The study on the global craniomaxillofacial implants market includes qualitative insights such as drivers, restraints, challenges and opportunities
- Additionally, the market has been evaluated using the Porter’s five forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of product type, application site, material type and property type. Moreover, the study on craniomaxillofacial implants market provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments
- The study includes the profiles of key players operating in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global craniomaxillofacial implants market is suitable for all the market players such as manufacturer and distributors
- Healthcare institution like government hospitals, private hospitals, specialty hospitals and others
- Venture capitalists and investors looking for more information on the future outlook of the global craniomaxillofacial implants market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global craniomaxillofacial implants market
The craniomaxillofacial implants market is expected to grow with a CAGR of 7%. The increasing need for minimally invasive surgeries and the increasing frequency of facial fractures is the major factor which assists in driving the growth of the market. COVID 19 stimulates the growth of healthcare centers. The craniomaxillofacial implants market has shown no negative impact on COVID 19 pandemic.
In the future, the make will face a high degree of competition from its rivals.
The international market player will continuously focus on offering technically advanced and innovative products for their customers. Some of the leading players that played a major role in the development of the market are Medtronic, Stryker’s, Zimmer Biomet, Depuy Synthes including others.
Based on type, the craniomaxillofacial implants market is classified into ten types Mid Face Implants, Mandibular Orthognathic Implants, Cranial or Neuro Implants, Contourable Mesh, Bone Graft Substitutes, Distraction Systems, Total TMJ Replacement Systems, Cranial Flap Fixation Systems, Thoracic Fixation Systems, and Dural Repair Products. Mid-Face Implants hold the largest market share in the year 2020. The rising number of accidents across the countries is the major contributing factor that helps in promoting the growth of the market.
Based on application, the craniomaxillofacial implants are classified into internal fixators and external fixators. The Internal fixators dominate the global craniomaxillofacial implants. The same segment accounts for more than 72% of the global market share. The growth is mainly contributed due to the high demand for the products from the end-user industries. An internal fixator is a medical device used for internal fixation. The product is incorporated inside the body by performing invasive surgeries in order to stabilize the fractured bones. The internal fixators are costly compared with external fixators and generally made up of titanium and other metal alloys. It is estimated that out of 10, 6 fixators are of internal types.
Based on material type, the global craniomaxillofacial implants are classified into three types Titanium, other metals and alloys, Calcium Phosphate Ceramics, and Polymers/Biomaterials. The majority product of the craniomaxillofacial implants market is captured by Titanium, other metals, and alloys. The product consumes by the orthopedic industry are made up of titanium and alloy. Titanium alloys are ideally known for their chemical, biological, mechanical properties. The product finds its special importance and successfully expanded in the maxillofacial field. The internal fixators are normally made up of titanium and provide a new perspective for the treatment of traumatic injury, surgery, and maxillofacial oncology. The titanium used is available in the grade form ie. Grade 1, Grade 2, Grade 3, and Grade 4 and offer a high degree of biocompatibility.
Based on property type, the global craniomaxillofacial implants are classified into two types resorbable fixators and non-resorbable fixators. This growth is mainly driven by seeing the benefit of resorbable fixators such as shorter healing time and no need for follow-up surgery to remove the fixator. The resorbable fixators provide better alternative options over non-resorbable fixators. The resorbable fixators market will grow at the highest CAGR% in the coming years.
The global report of the craniomaxillofacial implants market classified the market into five regions, North America, Europe, Asia Pacific, Latin America, and the Middle East, and Africa. Among all the regions, North America holds the largest market share in the year 2020. The growth of this region is mainly attributed due to the presence of advanced infrastructure. In North America, The United States of America alone accounts for approx. more than 80% of the market share in the year 2020. It is expected the craniomaxillofacial devices market in the United States was valued at more than 1 Million in the year 2019. According to the U.S. National Safety Council report, traffic deaths increased to 7.0% from 2018 to 2019. A total of 44,200 accidents were reported in 2018 and the record was found to be the largest in more than half a century. Furthermore, rising public awareness followed by increasing per capita healthcare expenditure in the country is the major contributing factor that promotes the growth of the market. Europe's craniomaxillofacial implants market is also flourishing due to the presence of promising market players like Stryker, Depuy Synthes, Zimmer Biomet, Medtronic, and Others.